KCT0001393
Completed
未知
A Pilot study to estimate the efficacy of foot reflexology on insomnia in cancer patient.
Comprehensive and Integrative Medical Institute0 sites13 target enrollmentTBD
ConditionsDiseases of the nervous system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the nervous system
- Sponsor
- Comprehensive and Integrative Medical Institute
- Enrollment
- 13
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) History of histologically or cytologically proven cancer.
- •2\) The Eastern Cooperative Oncology Group performance scale: 0\-2
- •3\) Patients who had received surgery or radiation therapy or chemotherapy more than 1 month ago.
- •4\) Patients who have experienced insomnia more than 3 months and the ISI (Insomnia Severity Index) score is more than 15\.
- •5\) Patients who are able to complete questionnaires.
- •6\) Patients who voluntarily agree to participate and sign the consent form themselves or the form is signed by their guardian
- •7\) Patients for whom follow\-up observations are possible throughout the study period.
Exclusion Criteria
- •1\) Liver dysfunction: AST, ALT is more than 1\.5 times compared with a normal standard.
- •2\) Kidney dysfunction: Creatine is more than 1\.5 times compared with a normal standard.
- •3\) Heart disease or uncontrolled hypertension(more than 160/100 mmHg)
- •4\) Patients who are not able to take foot reflexology
- •5\) Pregnant, breast\-feeding, or woman of childbearing potential not using adequate contraception
- •6\) Patients who are not suitable for this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The role of foot orthoses in children with developmental coordination disorderDevelopmental coordination disorder (DCD)Musculoskeletal DiseasesMotor skill disorderISRCTN59547425Canonbury Products Ltd (UK)30
Completed
Phase 2
Study of a combination of fenugreek/phaseolamin as a new weight loss agentObesityDiet and Nutrition - ObesityACTRN12607000130460Southern European Health Marketing Ltd39
Active, not recruiting
Not Applicable
Conjuran®(Polynucleotide) for knee OsteoarthritisDiseases of the musculo-skeletal system and connective tissueKCT0005555The Catholic University of Korea, Seoul St. Mary's Hospital15
Completed
Phase 2
A pilot trial to examine the effectiveness and feasibility of the mobile application-based cognitive behavioral therapy for depression and anxietydepression and anxietyJPRN-UMIN000042193Chiba University11
Completed
Phase 4
Exenatide -LAR in addition to standard care in Indigenous Australians with type 2 diabetes and effect on glycaemic controlType 2 DiabetesMetabolic and Endocrine - DiabetesACTRN12615000913572BakerIDI Heart and Diabetes Institute40